Address
New Enterprise Associates Inc
2855 Sand Hill Road
Menlo Park, CA 94025
United States
New Enterprise Associates Inc
1954 Greenspring Drive
Suite 600
Timonium, MD 21093
United States
Recent investment activity
Corporate information
Company type
Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies.Overview
New Enterprise Associates (NEA) is a venture capital firm that was founded in 1977. It is based in Menlo Park, California, and it focuses on providing early-stage and growth-stage financing to technology and life sciences companies. NEA has invested in a wide range of companies, including well-known brands such as Dropbox, Netflix, and Slack. NEA is one of the largest and most successful venture capital firms in the world, and it has raised more than $40 billion in capital over the course of its history. The firm is known for its expertise in identifying and investing in high-potential companies, and it has a track record of helping its portfolio companies grow and succeed. In addition to providing financing, NEA also offers a range of other services to its portfolio companies, including strategic advice, business development support, and access to its network of industry contacts. The firm is dedicated to helping its portfolio companies succeed, and it is committed to fostering innovation and growth in the technology and life sciences industries. Overall, New Enterprise Associates (NEA) is a leading venture capital firm that is focused on providing early-stage and growth-stage financing to technology and life sciences companies. The firm is known for its expertise in identifying and investing in high-potential companies, and it has helped many of its portfolio companies grow and succeed.
Funding rounds
Investment preferences
Selected investments
Displaying 501 - 525 of 706Company | Profile | Country | Funding | ||
---|---|---|---|---|---|
NeoTract Inc | N/A | ||||
Neuralieve Inc | N/A | ||||
NeuroPace Inc | N/A | ||||
Nexchem | N/A | ||||
Nova Medical Centers | N/A | ||||
Omthera Pharmaceuticals Inc | N/A | ||||
CHG Healthcare Services Inc | N/A Initial investment | ||||
Ardelyx Inc | N/A Initial investment | ||||
BENU Inc | N/A Initial investment | ||||
Biopure Corp | N/A Initial investment | ||||
BrainCells Inc | A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. | N/A Initial investment | |||
Cadence Pharmaceuticals Inc | Focused on in-licensing, developing, and commercializing proprietary product candidates principally for use in the hospital setting. | N/A Initial investment | |||
Cardioxyl Pharmaceuticals Inc | N/A Follow-on investment | ||||
Caremark Rx Inc | N/A Initial investment | ||||
Carticept Medical Inc | N/A Initial investment | ||||
Orchid BioSciences Inc | N/A | ||||
Clovis Oncology Inc | N/A Initial investment | ||||
Connectics Corp | N/A Initial investment | ||||
CVRx Inc | N/A Initial investment | ||||
Dermira Inc | Specialty pharmaceutical company with the goal of establishing a presence in the dermatology space by acquiring marketed products and a pipeline of la | N/A | |||
Elements Behavioral Health Inc | N/A | ||||
Evalve Inc | N/A | ||||
Genelabs Technologies Inc | N/A | ||||
GeneScreen Inc | N/A | ||||
Supernus Pharmaceuticals Inc | N/A |